Project Mitigate

The Project

The MITIGATE consortium consists of five key scientific partners in molecular analysis, multimodal imaging and minimally-invasive therapy (UHEI, MUI, UNITO, FHI, HM), four SME partners (Cage, AAA, Rapid, SCT), and EIBIR as coordinating partner. Eight work packages have been defined that tightly interlink the demands of developing the system platform for minimally-invasive, molecular imaging assisted biopsy, the molecular targeting of tumours, the innovative biotechnology for patient-individualised treatment and the multimodal imaging for therapy planning and monitoring.

Closed loop scheme